MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/rheumatology/keag443

Медицинская библиотека · Rheumatology (Oxford, England) · 2026

Describing flares: a mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases.

Piper Martha A, Tunks Alice, Bourgeois James A, Calderwood Lucy, D'Cruz David, Bortoluzzi Alessandra, Arunasalam Arjoon, Tayabali Shaista, Taylor Sydnae, Saha Pratyasha, Yates Max, Hamilton-Conaty Paige, Kaul Arvind, Sloan Melanie

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

Systemic autoimmune rheumatic diseases (SARDs) relapse and remit, with periods of increased disease activity called 'flares'. This study compared patient and clinician perspectives of flares.

METHODS

Mixed-methods approach combining an international co-produced survey and in-depth interviews. SLE patients and clinicians rated statements about flares on Likert scales from 'never' to 'always'. Quantitative data were analysed using t tests and ANOVA. Patient and clinician interviews were analysed thematically. Quantitative and qualitative analyses were triangulated by exploring converging, diverging and explanatory findings across the datasets.

RESULTS

Qualitative (N = 31 SARD patients, N = 12 clinicians) and quantitative (N = 443 SLE patients, N = 258 clinicians) results indicated differential patient and clinician perspectives. The main themes identified were: characteristics/consequences of flares; recognition of flares; and treatment for flares (medical and/or self-management). Patients and clinicians had significantly different mean ratings for 12/17 flare statements. Notably, regarding flare onset, 39% of patients compared with 14% of clinicians said flares 'often' or 'always' started within minutes or hours (P < 0.001). We found differences in identification of flares, with patients rating 'patient can tell' significantly higher than clinicians (P < .001), including awareness of prodromal symptoms. Clinicians were significantly more likely to think flares required increased (P = 0.005) or new (P < .001) medication. There was consensus about the impact of flares on wellbeing.

CONCLUSION

We highlight differences in how SARD patients and clinicians describe flares, notably related to onset, recognition and intervention. These differences challenge the prevailing reliance on clinician-derived disease activity measures and biomarkers for flare assessment, highlighting the need for integration of patient and clinician perspectives.

Для цитирования: Piper Martha A, Tunks Alice, Bourgeois James A, Calderwood Lucy, D'Cruz David, Bortoluzzi Alessandra, Arunasalam Arjoon, Tayabali Shaista, Taylor Sydnae, Saha Pratyasha, Yates Max, Hamilton-Conaty Paige, Kaul Arvind, Sloan Melanie. Describing flares: a mixed methods study comparing patient and clinician perspectives in systemic lupus erythematosus and other rheumatic diseases.. Rheumatology (Oxford, England). 2026. DOI: 10.1093/rheumatology/keag443.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.